CliffBio
small molecule

MYCELEX-7

CLOTRIMAZOLE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameMYCELEX-7
Active ingredientCLOTRIMAZOLE
Strength100MG
Dosage formTABLET
RouteVAGINAL
ModalitySmall molecule
FDA approvalDecember 1991
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.